MIR6508

Across TCGA pan-cancer cohorts, MIR6508 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MIR6508 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher MIR6508 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6508 expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.

CHOL, MESO, and UCS are the cancer types where MIR6508 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.024	0.675	<.001	99	view →
MESO	OS	Tertile	All	0.052	0.528	.016	54	view →
UCS	OS	Tertile	All	0.248	0.605	.007	36	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
STAD	OS	Tertile	II,III,IV	0.461	0.727	.005	36	view →
KIRP	DFS	Tertile	II,III,IV	0.520	0.765	.002	36	view →
BLCA	OS	Tertile	IV	0.190	0.597	.007	24	view →
SKCM	DFS	Tertile	IV	0.016	0.454	<.001	18	view →
KIRC	DFS	Tertile	IV	0.204	0.504	.017	18	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	18	view →
PCPG	OS	Tertile	All	0.286	0.976	<.001	18	view →
LUSC	OS	Tertile	All	0.722	0.381	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MIR6508–CHOL (OS)

Open the CHOL breakdown →